# Johnson & Johnson (JNJ) — Q2-2012 Earnings Results

**Report date:** 2012-07-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2012

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.30 | N/A | +0.78% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings results, highlighting their commitment to quality. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on delivering quality products to our customers.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Johnson & Johnson performed better than expected on earnings per share, which is a positive sign for the company. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is not available, making it difficult to assess immediate market sentiment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2012_